Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03122899 · ClinicalTrials.gov registry record · NA
Study of Bone Growth in the Sacroiliac Joint After Minimally Invasive Surgery With Titanium Implants
A NA study of Sacroiliac Dysfunction, sponsored by SI-BONE.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 11
- Study locations
NCT03122899: Completed NA study of Sacroiliac Dysfunction, sponsored by SI-BONE.
NCT03122899 is a NA study of Sacroiliac Dysfunction that has completed, run by SI-BONE. The registered enrollment target is 51 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 11 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03122899, a NA study of Sacroiliac Dysfunction, has completed, sponsored by SI-BONE.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 11
- Study locations
Study Summary
SALLY studies sacroiliac joint fusion with the iFuse-3D implant.
Primary Outcome
Percent surface area of the sacral end of the implants to which bone is adherent.
Conditions Studied
Interventions
- DEVICE SIJ fusion with iFuse-3D
Study Locations (11)
Colorado
- University of Colorado Hospital - Aurora
- Clin Tech Center for Spine Health - Johnstown
California
- Memorial Orthopaedic Surgical Group - Long Beach
Florida
- The B.A.C.K. Center - Melbourne
Illinois
- Orthopedic Center of Southern Illinois - Mount Vernon
Kentucky
- Bluegrass Orthopaedics - Lexington
Louisiana
- LSU Health Sciences Center, Department of Neurosurgery - New Orleans
Missouri
- Columbia Orthopaedic Group - Columbia
Oregon
- South Oregon Orthopedics - Medford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2017-10-03 |
| Est. Completion | 2024-06-19 |
| Phase | NA |
What the finished NCT03122899 record still lists
NCT03122899 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Sacroiliac Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which SIJ fusion with iFuse-3D is the first listed.
NCT03122899 lists 11 locations in 10 states (Colorado, California, Florida).
Frequently Asked Questions
What is clinical trial NCT03122899 about?
NCT03122899 is a clinical study titled "Study of Bone Growth in the Sacroiliac Joint After Minimally Invasive Surgery With Titanium Implants". SALLY studies sacroiliac joint fusion with the iFuse-3D implant.
What is the current status of trial NCT03122899?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2017-10-03. Estimated completion is 2024-06-19.
What conditions does trial NCT03122899 study?
This clinical trial studies the following conditions: Sacroiliac Dysfunction.
What interventions are being tested in trial NCT03122899?
The interventions under investigation include: SIJ fusion with iFuse-3D (DEVICE).
Who is sponsoring clinical trial NCT03122899?
This trial is sponsored by SI-BONE, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03122899 being conducted?
This trial has 11 study locations across California, Colorado, Florida, Illinois, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03122899's enrollment target sits among peer trials
51 1279th of 2000 higher than 722 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI